A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Interested in new trials?
Get alerts for new trials in your area by subscribing now
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.
These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.
Why choose Dallas for clinical trials?
Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.
Common conditions studied in Dallas
In Dallas, clinical trials encompass a broad spectrum of medical conditions and diseases, underscoring the city’s role as a leading center for innovative research.
Cardiovascular Diseases
Cardiovascular clinical trials in Dallas address a variety of heart-related conditions, including coronary artery disease, heart failure, and hypertension. Research focuses on pioneering therapies such as new-generation stents, novel anticoagulants, and innovative heart failure treatments.
Medical device clinical trials are also commonly explored, like implantable cardioverter-defibrillators (ICDs) and ventricular assist devices (VADs), as well as lifestyle interventions and surgical techniques aimed at improving cardiovascular health and reducing the incidence of heart disease.
Cancer
Dallas is at the forefront of cancer research, with trials investigating multiple types of malignancies including breast cancer, prostate cancer, lung cancer, and leukemia. Researchers are testing cutting-edge therapies such as CAR-T cell therapy, which involves engineering a patient’s own immune cells to target cancer, and new immune checkpoint inhibitors that boost the body’s ability to fight cancer.
Trials also focus on personalized medicine approaches, where treatments are tailored based on the genetic profile of both the patient and the tumor, aiming to enhance treatment efficacy and minimize side effects.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Neurological disorders
Trials in Dallas for neurological conditions include research on Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), and epilepsy. They may involve testing new pharmacological agents that target specific disease mechanisms, experimental treatments such as stem cell therapy or gene editing, and novel approaches like deep brain stimulation or cognitive rehabilitation programs.
The city’s research efforts are driven by the increasing prevalence of neurodegenerative disorders and the need for more effective treatments to manage these complex conditions.
Diabetes and endocrine disorders
Clinical trials in Dallas have a broad focus on managing diabetes and endocrine disorders, including type 1 and type 2 diabetes, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS).
Research often explores new insulin delivery systems, such as smart insulin pens and continuous glucose monitors, as well as innovative medications that address insulin resistance and hormonal imbalances. Trials also include studies on lifestyle interventions and weight management to improve long-term outcomes for individuals with diabetes and related conditions.
Autoimmune diseases
Many clinical trials in Dallas target autoimmune diseases like rheumatoid arthritis, lupus, and dermatological conditions such as psoriasis. Researchers are evaluating new biologic agents that specifically inhibit immune system components involved in these diseases, as well as combination therapies that aim to enhance efficacy and reduce the need for corticosteroids.
These trials also investigate novel approaches to manage symptoms and improve quality of life for patients with chronic autoimmune conditions.
Respiratory diseases
Trials for respiratory conditions in Dallas include studies on asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research efforts focus on developing new inhaled medications, such as biologics that target specific inflammatory pathways in asthma, and advanced drug delivery systems that improve medication adherence and effectiveness.
Infectious diseases
Trials in infectious diseases cover a wide range of conditions, including HIV, hepatitis C, and influenza. Research includes the development of new antiviral medications, vaccines for emerging and re-emerging infections, and strategies for improving treatment adherence and outcomes. Trials may also investigate new diagnostic tools and treatment protocols to enhance disease management and prevention.
Local regulations and guidelines
In Dallas, clinical trials are governed by a comprehensive framework that ensures ethical and regulatory compliance. Federal oversight is provided by the U.S. Food and Drug Administration (FDA), which sets standards for trial design, conduct, and reporting. All studies must be reviewed and approved by an Institutional Review Board (IRB), ensuring the protection of participant rights and adherence to ethical guidelines.
Researchers in Dallas are required to follow Good Clinical Practice (GCP) standards, which include strict protocols for data management, participant recruitment, and reporting adverse events. State-specific regulations from the Texas Medical Board also apply, alongside federal and privacy laws such as the Health Insurance Portability and Accountability Act (HIPAA), which safeguard participants' personal health information. The informed consent process is also crucial, providing participants with detailed information about the study and their rights.
Benefits of participating in clinical trials
Joining a clinical trial provides the exclusive benefit of accessing novel treatments and therapies before they become widely available. Participants also benefit from exceptional care by leading healthcare professionals, who provide thorough monitoring and customized support throughout the study.
Participating in clinical trials is essential for progressing medical research and may lead to groundbreaking advancements in treatments or preventative care. By volunteering in a trial, individuals not only gain early access to innovative medical solutions but also play a key role in advancing scientific knowledge, thereby contributing to future improvements in healthcare for others.
How to enroll in a clinical trial in Dallas
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.